Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity-Reference-Cited by-同舟云学术

Sulforaphane covalently interacts with the transglutaminase 2 cancer maintenance protein to alter its structure and suppress its activity

Published:2021-10-05 Issue:1 Volume:61 Page:19-32
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Molecular Carcinogenesis

Author:

Rorke Ellen A.¹,Adhikary Gautam²,Szmacinski Henryk²,Lakowicz Joseph R.²,Weber David J.²³⁴,Godoy‐Ruiz Raquel²⁴,Puranik Purushottamachar²⁴,Keillor Jeffrey W.⁵^ORCID,Gates Eric W. J.⁵,Eckert Richard L.²³⁴^ORCID

Affiliation:

1. Department of Microbiology and Immunology University of Maryland School of Medicine Baltimore Maryland USA

2. Department of Biochemistry and Molecular Biology University of Maryland School of Medicine Baltimore Maryland USA

3. Marlene and Stewart Greenebaum Comprehensive Cancer Center University of Maryland School of Medicine Baltimore Maryland USA

4. Center for Biomolecular Therapueutics University of Maryland School of Medicine Baltimore Maryland USA

5. Department of Chemistry University of Ottawa Ottawa Ontario Canada

Funder

National Institutes of Health

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23356

Reference68 articles.

1. Hallmarks of Cancer: The Next Generation

2. The cancer stem cell: premises, promises and challenges

3. Transglutaminase is a tumor cell and cancer stem cell survival factor

4. Identification of a Population of Epidermal Squamous Cell Carcinoma Cells with Enhanced Potential for Tumor Formation

5. Transglutaminase Is Required for Epidermal Squamous Cell Carcinoma Stem Cell Survival

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reassessing the role of phytochemicals in cancer chemoprevention;Biochemical Pharmacology;2024-03

2. Natural Compounds in Non-Melanoma Skin Cancer: Prevention and Treatment;Molecules;2024-02-04

3. Sulforaphane Target Protein Prediction: A Bioinformatics Analysis;Applied Sciences;2024-01-26

4. Cell-Impermeable Inhibitors Confirm That Intracellular Human Transglutaminase 2 Is Responsible for the Transglutaminase-Associated Cancer Phenotype;International Journal of Molecular Sciences;2023-08-08

5. ΔNp63α in cancer: importance and therapeutic opportunities;Trends in Cell Biology;2023-04